JACC:先天性心脏病术后的残余问题越大,患者临床预后越差!

2021-06-13 Nebula MedSci原创

先天性心脏病婴幼儿接受复杂手术治疗后的残余问题明显影响患者的临床结果

患者特征、术前状态和围手术期因素都可以影响先天性心脏病手术治疗后的结果。手术后的残留问题(即先天性心脏手术达到预期结果的程度)通常被认为是决定短期和长期预后的最重要因素之一。

RLS(残留问题评分)研究旨在探索不同复发性手术中残留问题的严重程度对术后结果的影响。

这是一项前瞻性、多中心的观察性研究,在17个地点招募接受5种常见手术(法洛四联症修补术、完全房室间隔缺损修补术、动脉转换手术、缩窄或间断弓合并室间隔缺损修补术、诺伍德手术)的婴幼儿。根据术后超声心动图和临床事件确定残留问题评分:RLS1:轻微或无残留;RLS2:小残留;RLS3:出院前需对残留问题进行干预治疗。主要预后是存活时间和术后30天内的出院率(诺伍德手术治疗的是60天内的出院率)。次要预后是疗程,包括主要医疗事件和住院天数。

不同手术后不同级别残余问题的比例

总体上,共招募了1149位接受手术治疗的婴幼儿:法洛四联症修补术 250位、完全房室间隔缺损修补术 249位、动脉转换手术 251位、缩窄或间断弓合并室间隔缺损修补术 150位、诺伍德手术 249位

不同级别残余问题对不同手术后患儿的存活时间和出院率的影响

与RLS1相比,RLS3是接受5种手术的婴幼儿存活时间短、出院率低和术后住院时间长的独立风险因素(p≤0.02),还是接受缩窄或间断弓合并室间隔缺损修补术和诺伍德手术治疗的婴幼儿的所有次要结果的独立风险因素(p≤0.03)。RLS1和RLS2之间的预后无明显差异。仅RLS可以解释5%(法洛四联症修复)到20%(诺伍德手术)的术后主要预后差异。

对术前因素进行调整后,先天性心脏病婴幼儿接受复杂手术治疗后的残余问题对住院结果的影响最大。轻微残余问题的影响最小。该研究结果或可为外科医生在考虑旁路手术修复残余问题的短期风险和收益时提供指导。

原始出处:

Nathan Meena,Levine Jami C,Van Rompay Maria I et al. Impact of Major Residual Lesions on Outcomes After Surgery for Congenital Heart Disease.[J] .J Am Coll Cardiol, 2021, 77: 2382-2394. https://doi.org/10.1016/j.jacc.2021.03.304

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1854947, encodeId=b59c185494e91, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Wed Mar 09 03:41:30 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326812, encodeId=d78c1326812b5, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Jun 15 07:41:30 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369548, encodeId=82121369548c6, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Tue Jun 15 07:41:30 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534761, encodeId=f92a1534e6153, content=<a href='/topic/show?id=6be9230842e' target=_blank style='color:#2F92EE;'>#临床预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23084, encryptionId=6be9230842e, topicName=临床预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a72412536387, createdName=budeshao, createdTime=Tue Jun 15 07:41:30 CST 2021, time=2021-06-15, status=1, ipAttribution=)]
    2022-03-09 hbwxf
  2. [GetPortalCommentsPageByObjectIdResponse(id=1854947, encodeId=b59c185494e91, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Wed Mar 09 03:41:30 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326812, encodeId=d78c1326812b5, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Jun 15 07:41:30 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369548, encodeId=82121369548c6, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Tue Jun 15 07:41:30 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534761, encodeId=f92a1534e6153, content=<a href='/topic/show?id=6be9230842e' target=_blank style='color:#2F92EE;'>#临床预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23084, encryptionId=6be9230842e, topicName=临床预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a72412536387, createdName=budeshao, createdTime=Tue Jun 15 07:41:30 CST 2021, time=2021-06-15, status=1, ipAttribution=)]
    2021-06-15 仁心济世
  3. [GetPortalCommentsPageByObjectIdResponse(id=1854947, encodeId=b59c185494e91, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Wed Mar 09 03:41:30 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326812, encodeId=d78c1326812b5, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Jun 15 07:41:30 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369548, encodeId=82121369548c6, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Tue Jun 15 07:41:30 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534761, encodeId=f92a1534e6153, content=<a href='/topic/show?id=6be9230842e' target=_blank style='color:#2F92EE;'>#临床预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23084, encryptionId=6be9230842e, topicName=临床预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a72412536387, createdName=budeshao, createdTime=Tue Jun 15 07:41:30 CST 2021, time=2021-06-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1854947, encodeId=b59c185494e91, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Wed Mar 09 03:41:30 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326812, encodeId=d78c1326812b5, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Jun 15 07:41:30 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369548, encodeId=82121369548c6, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Tue Jun 15 07:41:30 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534761, encodeId=f92a1534e6153, content=<a href='/topic/show?id=6be9230842e' target=_blank style='color:#2F92EE;'>#临床预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23084, encryptionId=6be9230842e, topicName=临床预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a72412536387, createdName=budeshao, createdTime=Tue Jun 15 07:41:30 CST 2021, time=2021-06-15, status=1, ipAttribution=)]

相关资讯

J Cardiothorac Surg:早期口服母乳刺激有益于先心病术后婴儿早期喂养行为的建立

随着产前诊断、心脏外科技术和围手术期重症监护的改进,先天性心脏病(CHD)婴儿患者的生存率明显提高。在围手术期,心脏手术后婴儿喂养的作用日益突出,除了维持心肺功能和预防术后并发症外,营养是另一个重点。

JAHA:先天性心脏病患者接受心脏再同步化治疗的长期预后

先天性心脏病患者接受CRT与约50%的患者可接受的生存期和长期反应相关。CRT继续顺利进行的可能性不大。

专家访谈:郑雄、张臻:抓住机遇,开拓心外科先天性心脏病介入治疗新领域

先天性心脏病(简称“先心病”)占我国出生缺陷的首位,而随着新技术、新器械、新理念的不断出现,心外科在先心病诊疗中所扮演的角色也在不断发生转变。

JAHA:先天性心脏病妇女妊娠的产妇和新生儿结局分析

当代患有CHD的妇女妊娠通常对产妇和新生儿都有较成功的结局。然而,随着产妇CHD严重程度的增加,许多发病率和新生儿死亡率的风险也随之增加。

JAMA Netw Open:先天性心脏病患儿手术治疗后患高血压的长期风险是普通儿童的12倍!

先天性心脏病患儿手术治疗后患高血压的长期风险是普通儿童的12倍!

Radiology:母体高氧状态对先天性心脏病胎儿有何影响?

越来越多报道指出,妊娠晚期胎儿大脑发育受损为复杂先天性心脏病(CHD)幸存者的脑损伤和神经发育障碍的一个促进因素。现有证据表明,胎儿供氧过程的改变可能导致这一高危胎儿群体的异常脑发育,并提高了母体过氧